title: Dose-dependent acceleration in the delayed effects of neonatal oral exposure to low-dose 17α-ethynylestradiol on reproductive functions in female Sprague-Dawley rats.
abstract: Xenoestrogen exposure during the critical period of sexual differentiation of the brain causes delayed effects on female reproduction. We investigated the internal dose of orally administered ethynylestradiol (EE) during the critical period and its delayed effects by administering 0 (vehicle control), 0.4, or 2 μg/kg EE to female Sprague-Dawley rats for 5 days from postnatal day (PND) 1. Determination of serum EE level 24 hr after the initial dosing and 6 and 24 hr after the final dosing of 2 μg/kg indicated that the administered EE entered the circulation and cleared after every administration. Although the treatment did not affect physical development, including growth, eyelid opening, and vaginal opening, the estrous cycle was arrested from postnatal week (PNW) 12 even with 0.4 μg/kg EE, with an inverse correlation between doses and arresting ages. Although ovarian morphology at PNW 22-23 indicated that the treatment caused long-term anovulation and cystic follicle formation, the number of primordial follicles at PNW 22-23 was similar among the groups. Because this number was lower than that at PND 10 in all groups, primordial follicles may have been consumed under long-term anovulation. The treatment also caused other abnormalities, including mammary gland hyperplasia, increase in pituitary and liver weights, and decrease in the uterine weight. Because the highest circulating EE level in the 2 μg/kg-treated neonates is considered to be comparable to the physiological range of estradiol-17β, we concluded that a slight increase in the circulating estrogens during the neonatal period exerts irreversible delayed effects.
authors.affiliation: Laboratory of Comparative Toxicology, School of Veterinary Medicine.
authors.forename: Mariko
authors.initials: M
authors.lastname: Shirota
authors.forename: Jun
authors.initials: J
authors.lastname: Kawashima
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Nakamura
authors.forename: Junichi
authors.initials: J
authors.lastname: Kamiie
authors.forename: Kinji
authors.initials: K
authors.lastname: Shirota
authors.forename: Midori
authors.initials: M
authors.lastname: Yoshida
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn; D000858:Anovulation / Q000139:chemically induced; D001921:Brain / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D030762:Estrous Cycle / Q000187:drug effects; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects; D042361:Mammary Glands, Human / Q000187:drug effects; D009929:Organ Size / Q000187:drug effects; D006080:Ovarian Follicle / Q000187:drug effects; D010053:Ovary / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects; D017207:Rats, Sprague-Dawley; D012098:Reproduction / Q000187:drug effects*; D012733:Sex Differentiation / Q000187:drug effects; D014599:Uterus / Q000187:drug effects
chemical_list: D004997:Ethinyl Estradiol